DURECT Corporation (DRRX): Price and Financial Metrics

DRRX POWR Grades

• Quality is the dimension where DRRX ranks best; there it ranks ahead of 74.89% of US stocks.
• The strongest trend for DRRX is in Sentiment, which has been heading up over the past 154 days.
• DRRX's current lowest rank is in the Momentum metric (where it is better than 10.72% of US stocks).

DRRX Stock Summary

• DRRX has a higher market value than only 19.88% of US stocks; more precisely, its current market capitalization is $105,271,245.
• Of note is the ratio of DURECT CORP's sales and general administrative expense to its total operating expenses; just 15.05% of US stocks have a lower such ratio.
• As for revenue growth, note that DRRX's revenue has grown 323.85% over the past 12 months; that beats the revenue growth of 97.12% of US companies in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to DURECT CORP are GERN, HYLN, IPSC, EVGN, and OGEN.
• DRRX's SEC filings can be seen here. And to visit DURECT CORP's official web site, go to www.durect.com.

DRRX Valuation Summary

• DRRX's price/sales ratio is 4.7; this is 135% higher than that of the median Healthcare stock.
• DRRX's price/sales ratio has moved down 16.3 over the prior 243 months.

Below are key valuation metrics over time for DRRX.

DRRX Growth Metrics

Its 2 year net cashflow from operations growth rate is now at -925.28%.
• The 5 year net cashflow from operations growth rate now stands at 114.28%.
• Its year over year net cashflow from operations growth rate is now at 12.02%.

DRRX's revenue has moved up $9,240,000 over the prior 70 months.

The table below shows DRRX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	23.265	-28.98	-31.872
2022-06-30	13.453	-34.11	-39.378
2022-03-31	13.68	-32.161	-36.973
2021-12-31	13.977	-37.311	-36.265
2021-09-30	5.489	-34.58	-24.897
2021-06-30	6.007	-35.905	-24.252

DRRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• DRRX has a Quality Grade of C, ranking ahead of 38.99% of graded US stocks.
• DRRX's asset turnover comes in at 0.065 -- ranking 305th of 680 Pharmaceutical Products stocks.
• CCXI, LCI, and BHC are the stocks whose asset turnover ratios are most correlated with DRRX.

The table below shows DRRX's key quality metrics over time.